Salt: Sumatriptan
Therapeutic Description: Antimigraine Preparations
Category: 5HT1 agonist.
Pregnancy: Risk cannot be ruled out.
Lactation: Caution advised or effect undetermined.
Contraindications: Ischaemic heart disease, previous MI, cerebrovascular accident, coronary vasospasm, Prinzmetal's angina, moderate and severe hypertension, uncontrolled mild hypertension, severe hepatic impairment, peripheral vascular disease, transient ischaemic attack.
Precautions: Cardiac disease, risk factors for ischaemic heart disease; assess patients before initiating therapy. Hepatic or renal impairment. Controlled hypertension. History of, or risk factors for seizures. Sulphonamide sensitivity. Driving or operating machinery.
Treatment of acute migraine attacks, with or without aura, only where there is a clear diagnosis.
Migraine, cluster headache: Adults: 25 mg (taken with fluids); Max recommended dose is 100 mg. If a satisfactory response has not been obtained at 2 hour a 2nd dose of up to 100 mg may be given. Efficacy of this 2nd dose has not been examined. If a headache returns, a
Administered by SC. It should not be given by other routes of administration.
Stability: Intact containers should be stored between 2 and 30 degree centigrade and protected from light.
MAOIs, ergotamine, SSRIs, St. John's Wort.
Tingling, dizziness, drowsiness, increases in BP, flushing, GI upset, sensation of heaviness, pressure or heat, pain, weakness. If angina-like symptoms (transient chest pain or throat symptoms) occur, withdraw and investigate immediately.
Strength Pack Size PKR
100 mg2's512.00
50 mg2's330.00

Your medicine formula resulted in the following types of medicine type. Please select to proceed.